Antibiotic-impregnated plaster of Paris beads. Trials with teicoplanin. 1992

V Dacquet, and A Varlet, and R N Tandogan, and M M Tahon, and L Fournier, and F Jehl, and H Monteil, and G Bascoulergue
Institut Calot, Berck-sur-Mer, France.

Teicoplanin-impregnated plaster of Paris beads were made and in vitro release properties were studied. Teicoplanin was released in an initial massive dose, with a rapid decline during the first three days, followed by a slowly declining prolonged release up to 30 days. The release tested by diffusion in gelose and high-performance liquid chromatography was found to be 21.4% and 28.2%, respectively, of the amount theoretically present in the beads. Plaster of Paris is a resorbable, nontoxic biomaterial that has already been used to fill dead spaces in bone and deliver antibiotics in the treatment of chronic osteomyelitis. The addition of teicoplanin, a new antistaphylococcal agent with low known bacterial resistance, is a promising alternative. Follow-up tests in vivo, simulating local conditions of the osteomyelitic bone, are necessary to prove efficacy.

UI MeSH Term Description Entries
D008826 Microbial Sensitivity Tests Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses). Bacterial Sensitivity Tests,Drug Sensitivity Assay, Microbial,Minimum Inhibitory Concentration,Antibacterial Susceptibility Breakpoint Determination,Antibiogram,Antimicrobial Susceptibility Breakpoint Determination,Bacterial Sensitivity Test,Breakpoint Determination, Antibacterial Susceptibility,Breakpoint Determination, Antimicrobial Susceptibility,Fungal Drug Sensitivity Tests,Fungus Drug Sensitivity Tests,Sensitivity Test, Bacterial,Sensitivity Tests, Bacterial,Test, Bacterial Sensitivity,Tests, Bacterial Sensitivity,Viral Drug Sensitivity Tests,Virus Drug Sensitivity Tests,Antibiograms,Concentration, Minimum Inhibitory,Concentrations, Minimum Inhibitory,Inhibitory Concentration, Minimum,Inhibitory Concentrations, Minimum,Microbial Sensitivity Test,Minimum Inhibitory Concentrations,Sensitivity Test, Microbial,Sensitivity Tests, Microbial,Test, Microbial Sensitivity,Tests, Microbial Sensitivity
D002133 Calcium Sulfate A calcium salt that is used for a variety of purposes including: building materials, as a desiccant, in dentistry as an impression material, cast, or die, and in medicine for immobilizing casts and as a tablet excipient. It exists in various forms and states of hydration. Plaster of Paris is a mixture of powdered and heat-treated gypsum. Dental Gypsum,Dental Stone, Artificial,Gypsum,Plaster of Paris,Alabaster,Anhydrous Sulfate of Lime,Artificial Dental Stone,Calcium Sulfate (1:1), Dihydrate,Calcium Sulfate (1:1), Hemihydrate,Calcium Sulfate (2:1),Calcium Sulfate Dihydrate,Calcium Sulfate, Anhydrous,Calcium Sulfate, Dihydrate,Calcium Sulfate, Hemihydrate,Calcium Sulphate,Drierite,Gypsite,Gypsum, Dental,Karstenite,Stone, Artificial Dental
D002851 Chromatography, High Pressure Liquid Liquid chromatographic techniques which feature high inlet pressures, high sensitivity, and high speed. Chromatography, High Performance Liquid,Chromatography, High Speed Liquid,Chromatography, Liquid, High Pressure,HPLC,High Performance Liquid Chromatography,High-Performance Liquid Chromatography,UPLC,Ultra Performance Liquid Chromatography,Chromatography, High-Performance Liquid,High-Performance Liquid Chromatographies,Liquid Chromatography, High-Performance
D004337 Drug Carriers Forms to which substances are incorporated to improve the delivery and the effectiveness of drugs. Drug carriers are used in drug-delivery systems such as the controlled-release technology to prolong in vivo drug actions, decrease drug metabolism, and reduce drug toxicity. Carriers are also used in designs to increase the effectiveness of drug delivery to the target sites of pharmacological actions. Liposomes, albumin microspheres, soluble synthetic polymers, DNA complexes, protein-drug conjugates, and carrier erythrocytes among others have been employed as biodegradable drug carriers. Drug Carrier
D004353 Drug Evaluation, Preclinical Preclinical testing of drugs in experimental animals or in vitro for their biological and toxic effects and potential clinical applications. Drug Screening,Evaluation Studies, Drug, Pre-Clinical,Drug Evaluation Studies, Preclinical,Drug Evaluations, Preclinical,Evaluation Studies, Drug, Preclinical,Evaluation, Preclinical Drug,Evaluations, Preclinical Drug,Medicinal Plants Testing, Preclinical,Preclinical Drug Evaluation,Preclinical Drug Evaluations,Drug Screenings,Screening, Drug,Screenings, Drug
D006020 Glycopeptides Proteins which contain carbohydrate groups attached covalently to the polypeptide chain. The protein moiety is the predominant group with the carbohydrate making up only a small percentage of the total weight. Glycopeptide
D000900 Anti-Bacterial Agents Substances that inhibit the growth or reproduction of BACTERIA. Anti-Bacterial Agent,Anti-Bacterial Compound,Anti-Mycobacterial Agent,Antibacterial Agent,Antibiotics,Antimycobacterial Agent,Bacteriocidal Agent,Bacteriocide,Anti-Bacterial Compounds,Anti-Mycobacterial Agents,Antibacterial Agents,Antibiotic,Antimycobacterial Agents,Bacteriocidal Agents,Bacteriocides,Agent, Anti-Bacterial,Agent, Anti-Mycobacterial,Agent, Antibacterial,Agent, Antimycobacterial,Agent, Bacteriocidal,Agents, Anti-Bacterial,Agents, Anti-Mycobacterial,Agents, Antibacterial,Agents, Antimycobacterial,Agents, Bacteriocidal,Anti Bacterial Agent,Anti Bacterial Agents,Anti Bacterial Compound,Anti Bacterial Compounds,Anti Mycobacterial Agent,Anti Mycobacterial Agents,Compound, Anti-Bacterial,Compounds, Anti-Bacterial
D001412 Bacillus subtilis A species of gram-positive bacteria that is a common soil and water saprophyte. Natto Bacteria,Bacillus subtilis (natto),Bacillus subtilis subsp. natto,Bacillus subtilis var. natto
D013211 Staphylococcus aureus Potentially pathogenic bacteria found in nasal membranes, skin, hair follicles, and perineum of warm-blooded animals. They may cause a wide range of infections and intoxications.
D013242 Sterilization The destroying of all forms of life, especially microorganisms, by heat, chemical, or other means.

Related Publications

V Dacquet, and A Varlet, and R N Tandogan, and M M Tahon, and L Fournier, and F Jehl, and H Monteil, and G Bascoulergue
January 2014, Veterinary and comparative orthopaedics and traumatology : V.C.O.T,
V Dacquet, and A Varlet, and R N Tandogan, and M M Tahon, and L Fournier, and F Jehl, and H Monteil, and G Bascoulergue
August 2010, Veterinary surgery : VS,
V Dacquet, and A Varlet, and R N Tandogan, and M M Tahon, and L Fournier, and F Jehl, and H Monteil, and G Bascoulergue
June 1990, Pathologie-biologie,
V Dacquet, and A Varlet, and R N Tandogan, and M M Tahon, and L Fournier, and F Jehl, and H Monteil, and G Bascoulergue
January 1993, Revue de chirurgie orthopedique et reparatrice de l'appareil moteur,
V Dacquet, and A Varlet, and R N Tandogan, and M M Tahon, and L Fournier, and F Jehl, and H Monteil, and G Bascoulergue
January 2003, Veterinary surgery : VS,
V Dacquet, and A Varlet, and R N Tandogan, and M M Tahon, and L Fournier, and F Jehl, and H Monteil, and G Bascoulergue
April 1991, Orthopaedic review,
V Dacquet, and A Varlet, and R N Tandogan, and M M Tahon, and L Fournier, and F Jehl, and H Monteil, and G Bascoulergue
January 1984, The Journal of the Kentucky Medical Association,
V Dacquet, and A Varlet, and R N Tandogan, and M M Tahon, and L Fournier, and F Jehl, and H Monteil, and G Bascoulergue
March 1994, The Journal of trauma,
V Dacquet, and A Varlet, and R N Tandogan, and M M Tahon, and L Fournier, and F Jehl, and H Monteil, and G Bascoulergue
November 1991, Surgical technology international,
V Dacquet, and A Varlet, and R N Tandogan, and M M Tahon, and L Fournier, and F Jehl, and H Monteil, and G Bascoulergue
February 1997, Antimicrobial agents and chemotherapy,
Copied contents to your clipboard!